227 related articles for article (PubMed ID: 30259975)
21. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.
de Silva HC; Lin MZ; Phillips L; Martin JL; Baxter RC
Cell Mol Life Sci; 2019 May; 76(10):2015-2030. PubMed ID: 30725116
[TBL] [Abstract][Full Text] [Related]
22. Identification of miRNA modulators to PARP inhibitor response.
Neijenhuis S; Bajrami I; Miller R; Lord CJ; Ashworth A
DNA Repair (Amst); 2013 Jun; 12(6):394-402. PubMed ID: 23570906
[TBL] [Abstract][Full Text] [Related]
23. A deregulated m
Lu X; Peng L; Ding J; Li Y; Li Q; Rao M; Shu T; He X; Liu C; Ye J; Liu W; You H
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2304534120. PubMed ID: 37782793
[TBL] [Abstract][Full Text] [Related]
24. Abrogation of KLF5 sensitizes
Zhang Z; Liu Y; Xu Y; Xu Z; Jia J; Jin Y; Wang W; Liu L
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):576-585. PubMed ID: 38433576
[TBL] [Abstract][Full Text] [Related]
25. The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
da Motta LL; Ledaki I; Purshouse K; Haider S; De Bastiani MA; Baban D; Morotti M; Steers G; Wigfield S; Bridges E; Li JL; Knapp S; Ebner D; Klamt F; Harris AL; McIntyre A
Oncogene; 2017 Jan; 36(1):122-132. PubMed ID: 27292261
[TBL] [Abstract][Full Text] [Related]
26. BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin.
Endo S; Yoshino Y; Shirota M; Watanabe G; Chiba N
Cancer Res Commun; 2021 Nov; 1(2):90-105. PubMed ID: 36860287
[TBL] [Abstract][Full Text] [Related]
27. Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.
Nowsheen S; Cooper T; Stanley JA; Yang ES
PLoS One; 2012; 7(10):e46614. PubMed ID: 23071597
[TBL] [Abstract][Full Text] [Related]
28. Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation.
Sinha S; Paul S; Acharya SS; Das C; Dash SR; Bhal S; Pradhan R; Das B; Kundu CN
Med Oncol; 2024 Jan; 41(2):49. PubMed ID: 38184505
[TBL] [Abstract][Full Text] [Related]
29. Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies.
Hong L; Braden DC; Zhao Y; Skoko JJ; Chang F; Woodcock SR; Uvalle C; Casey A; Wood K; Salvatore SR; Asan A; Harkness T; Fagunloye A; Razzaghi M; Straub A; Spies M; Brown DD; Lee AV; Schopfer F; Freeman BA; Neumann CA
Redox Biol; 2023 Oct; 66():102856. PubMed ID: 37633047
[TBL] [Abstract][Full Text] [Related]
30. Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair.
Wang Y; Gao B; Zhang L; Wang X; Zhu X; Yang H; Zhang F; Zhu X; Zhou B; Yao S; Nagayama A; Lee S; Ouyang J; Koh SB; Eisenhauer EL; Zarrella D; Lu K; Rueda BR; Zou L; Su XA; Yeku O; Ellisen LW; Wang XS; Lan L
Nat Commun; 2024 Feb; 15(1):1568. PubMed ID: 38383600
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.
Holme H; Gulati A; Brough R; Fleuren EDG; Bajrami I; Campbell J; Chong IY; Costa-Cabral S; Elliott R; Fenton T; Frankum J; Jones SE; Menon M; Miller R; Pemberton HN; Postel-Vinay S; Rafiq R; Selfe JL; von Kriegsheim A; Munoz AG; Rodriguez J; Shipley J; van der Graaf WTA; Williamson CT; Ryan CJ; Pettitt S; Ashworth A; Strauss SJ; Lord CJ
Sci Rep; 2018 Jul; 8(1):10614. PubMed ID: 30006631
[TBL] [Abstract][Full Text] [Related]
32. BET inhibition as a new strategy for the treatment of gastric cancer.
Montenegro RC; Clark PG; Howarth A; Wan X; Ceroni A; Siejka P; Nunez-Alonso GA; Monteiro O; Rogers C; Gamble V; Burbano R; Brennan PE; Tallant C; Ebner D; Fedorov O; O'Neill E; Knapp S; Dixon D; Müller S
Oncotarget; 2016 Jul; 7(28):43997-44012. PubMed ID: 27259267
[TBL] [Abstract][Full Text] [Related]
33. Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors.
Garutti M; Pelizzari G; Bartoletti M; Malfatti MC; Gerratana L; Tell G; Puglisi F
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295913
[TBL] [Abstract][Full Text] [Related]
34. Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.
Bermes M; Rodriguez MJ; de Toledo MAS; Ernst S; Müller-Newen G; Brümmendorf TH; Chatain N; Koschmieder S; Baumeister J
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139386
[TBL] [Abstract][Full Text] [Related]
35. BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer.
Li X; Baek G; Ramanand SG; Sharp A; Gao Y; Yuan W; Welti J; Rodrigues DN; Dolling D; Figueiredo I; Sumanasuriya S; Crespo M; Aslam A; Li R; Yin Y; Mukherjee B; Kanchwala M; Hughes AM; Halsey WS; Chiang CM; Xing C; Raj GV; Burma S; de Bono J; Mani RS
Cell Rep; 2018 Jan; 22(3):796-808. PubMed ID: 29346775
[TBL] [Abstract][Full Text] [Related]
36. Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer.
Yndestad S; Engebrethsen C; Herencia-Ropero A; Nikolaienko O; Vintermyr OK; Lillestøl RK; Minsaas L; Leirvaag B; Iversen GT; Gilje B; Blix ES; Espelid H; Lundgren S; Geisler J; Aase HS; Aas T; Gudlaugsson EG; Llop-Guevara A; Serra V; Janssen EAM; Lønning PE; Knappskog S; Eikesdal HP
JCO Precis Oncol; 2023 Sep; 7():e2300338. PubMed ID: 38039432
[TBL] [Abstract][Full Text] [Related]
37. CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
McCleland ML; Mesh K; Lorenzana E; Chopra VS; Segal E; Watanabe C; Haley B; Mayba O; Yaylaoglu M; Gnad F; Firestein R
J Clin Invest; 2016 Feb; 126(2):639-52. PubMed ID: 26752646
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic editing of
He W; Zhu H; Zhang S; Shu G; Lei H; Wang M; Yin G; Ni X; Wu Q
Epigenetics; 2024 Dec; 19(1):2357518. PubMed ID: 38796857
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancer.
He H; Yang W; Shi Y; Chen X; Chen X; Hu X; Li X; Yang Y; Liu Z; Ye T; Wang N; Yu L
Eur J Med Chem; 2024 Jan; 264():115943. PubMed ID: 38039793
[TBL] [Abstract][Full Text] [Related]
40. An
Myers SH; Poppi L; Rinaldi F; Veronesi M; Ciamarone A; Previtali V; Bagnolini G; Schipani F; Ortega Martínez JA; Girotto S; Di Stefano G; Farabegoli F; Walsh N; De Franco F; Roberti M; Cavalli A
Eur J Med Chem; 2024 Feb; 265():116114. PubMed ID: 38194775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
